Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
International Journal of Molecular Sciences|August 28, 2025
Bacteriophages, Antibiotics and Probiotics: Exploring the Microbial Battlefield of Colorectal CancerCristian Constantin Volovat, Mihai Andrei Cosovanu, Madalina-Raluca Ostafe, et al.Pharmaceutics|January 28, 2026
Rewriting Tumor Entry Rules: Microfluidic Polyplexes and Tumor-Penetrating Strategies-A Literature ReviewSimona Ruxandra Volovat, Iolanda Georgiana Augustin, Constantin Volovat, et al.Diagnostics (Basel, Switzerland)|March 27, 2024
Machine Learning-Based Algorithms for Enhanced Prediction of Local Recurrence and Metastasis in Low Rectal Adenocarcinoma Using Imaging, Surgical, and Pathological DataCristian-Constantin Volovat, Dragos-Viorel Scripcariu, Diana Boboc, et al.Medicina (Kaunas, Lithuania)|February 24, 2024
Predicting the Feasibility of Curative Resection in Low Rectal Cancer: Insights from a Prospective Observational Study on Preoperative Magnetic Resonance Imaging AccuracyCristian-Constantin Volovat, Dragos-Viorel Scripcariu, Diana Boboc, et al.Journal of Chemotherapy (Florence, Italy)|May 29, 2015
The efficacy and safety of hepatic arterial infusion of oxaliplatin plus intravenous irinotecan, leucovorin and fluorouracil in colorectal cancer with inoperable hepatic metastasisSimona R Volovat, Constantin Volovat, Serban M Negru, et al.Pharmaceuticals (Basel, Switzerland)|April 27, 2024
A Holographic-Type Model in the Description of Polymer-Drug Delivery ProcessesIrina Nica, Constantin Volovat, Diana Boboc, et al.Experimental and Therapeutic Medicine|April 5, 2021
Nanomedicine to modulate immunotherapy in cutaneous melanoma (Review)Simona Ruxandra Volovat, Serban Negru, Cati Raluca Stolniceanu, et al.Pharmaceutics|February 26, 2022
The Landscape of Nanovectors for Modulation in Cancer ImmunotherapySimona-Ruxandra Volovat, Corina Lupascu Ursulescu, Liliana Gheorghe Moisii, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 10, 2016
Efficacy and safety of lipegfilgrastim compared with placebo in patients with non-small cell lung cancer receiving chemotherapy: post hoc analysis of elderly versus younger patientsConstantin Volovat, Igor Bondarenko, Oleg Gladkov, et al.Springerplus|July 9, 2015
Phase III, randomized, double-blind, placebo-controlled, multicenter study of lipegfilgrastim in patients with non-small cell lung cancer receiving myelosuppressive therapyConstantin Volovat, Igor M Bondarenko, Oleg A Gladkov, et al.Pageof 3